Laura Riboni

Milan, 20141, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 46 publications

Correction: Navone et al. Role of Luteolin as Potential New Therapeutic Option for Patients with Glioblastoma Through Regulation of Sphingolipid Rheostat. Int. J. Mol. Sci. 2024, 25, 130.

Correction: Navone et al. Role of Luteolin as Potential New Therapeutic Option for Patients with Glioblastoma Through Regulation of Sphingolipid Rheostat. Int. J. Mol. Sci. 2024, 25, 130.

Journal: International journal of molecular sciences

Published: April 30, 2026

Revealing erythropoietin variant EV-3 as novel driving force and immunotherapeutic target in human glioblastoma.

Revealing erythropoietin variant EV-3 as novel driving force and immunotherapeutic target in human glioblastoma.

Journal: Journal of experimental & clinical cancer research : CR

Published: September 27, 2025

Modeling Glioblastoma with Brain Organoids: New Frontiers in Oncology and Space Research.

Modeling Glioblastoma with Brain Organoids: New Frontiers in Oncology and Space Research.

Journal: International journal of molecular sciences

Published: September 20, 2025

In Vitro Validation of Pulsed Electromagnetic Field (PEMF) as an Effective Countermeasure Against Inflammatory-Mediated Intervertebral Disc Degeneration.

In Vitro Validation of Pulsed Electromagnetic Field (PEMF) as an Effective Countermeasure Against Inflammatory-Mediated Intervertebral Disc Degeneration.

Journal: JOR spine

Published: August 02, 2024

Testing calpain inhibition in tumor endothelial cells: novel targetable biomarkers against glioblastoma malignancy.

Testing calpain inhibition in tumor endothelial cells: novel targetable biomarkers against glioblastoma malignancy.

Journal: Frontiers in oncology

Published: December 13, 2023

Role of Luteolin as Potential New Therapeutic Option for Patients with Glioblastoma through Regulation of Sphingolipid Rheostat.

Role of Luteolin as Potential New Therapeutic Option for Patients with Glioblastoma through Regulation of Sphingolipid Rheostat.

Journal: International journal of molecular sciences

Published: October 25, 2023

Effects of Metformin as Add-On Therapy against Glioblastoma: An Old Medicine for Novel Oncology Therapeutics.

Effects of Metformin as Add-On Therapy against Glioblastoma: An Old Medicine for Novel Oncology Therapeutics.

Journal: Cancers

Published: February 21, 2022

Frontiers in Anti-Cancer Drug Discovery: Challenges and Perspectives of Metformin as Anti-Angiogenic Add-On Therapy in Glioblastoma.

Frontiers in Anti-Cancer Drug Discovery: Challenges and Perspectives of Metformin as Anti-Angiogenic Add-On Therapy in Glioblastoma.

Journal: Cancers

Published: December 01, 2021

Decreased serum level of sphingosine-1-phosphate: a novel predictor of clinical severity in COVID-19.

Decreased serum level of sphingosine-1-phosphate: a novel predictor of clinical severity in COVID-19.

Journal: EMBO molecular medicine

Published: September 15, 2020

Personalized and translational approach for malignant brain tumors in the era of precision medicine: the strategic contribution of an experienced neurosurgery laboratory in a modern neurosurgery and neuro-oncology department.

Personalized and translational approach for malignant brain tumors in the era of precision medicine: the strategic contribution of an experienced neurosurgery laboratory in a modern neurosurgery and neuro-oncology department.

Journal: Journal of the neurological sciences

Published: April 16, 2020

Sphingosine-1-Phosphate in the Tumor Microenvironment: A Signaling Hub Regulating Cancer Hallmarks.

Sphingosine-1-Phosphate in the Tumor Microenvironment: A Signaling Hub Regulating Cancer Hallmarks.

Journal: Cells

Published: December 20, 2019

Tumor-Educated Platelets and Angiogenesis in Glioblastoma: Another Brick in the Wall for Novel Prognostic and Targetable Biomarkers, Changing the Vision from a Localized Tumor to a Systemic Pathology.

Tumor-Educated Platelets and Angiogenesis in Glioblastoma: Another Brick in the Wall for Novel Prognostic and Targetable Biomarkers, Changing the Vision from a Localized Tumor to a Systemic Pathology.

Journal: Cells

Published: December 06, 2019

Showing 1-12 of 46

Last Updated: 09/26/2026